# A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression

> **NCT04423757** · PHASE2 · TERMINATED · sponsor: **Boehringer Ingelheim** · enrollment: 45 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** BI 1358894
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04423757
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-22
- **Primary completion:** 2022-04-19
- **Final completion:** 2022-05-08
- **Target enrollment:** 45 (ACTUAL)
- **Why stopped:** Recruitment challenges
- **Last updated:** 2023-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04423757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04423757, "A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04423757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*